Target intelligence / Profile preview

S100 calcium binding protein A15 (S100A15)

Target
S100A15
Molecular classification
Calcium-binding protein, EF-hand family protein, S100 protein family
01

Overview

S100 calcium binding protein A15 (commonly abbreviated as S100A15 and also known as Koebnerisin) is a member of the S100 family of calcium-binding proteins characterized by two EF-hand motifs. It is mainly expressed in the epidermis and plays a crucial role in the regulation of keratinocyte differentiation, antimicrobial host defense, inflammation, and epithelial tumorigenesis. S100A15 is upregulated in inflamed and psoriatic human skin, and its murine ortholog (mS100a7a15) is used in mouse models for these functions. The protein acts as a chemotactic factor, recruiting immune cells via RAGE, and modulates the cutaneous immunological response. It has been implicated in the progression of epithelial cancers such as breast cancer, but it is not an established therapeutic target

Other names
S100A7AS100A7L1S100A7fS100 calcium-binding protein A7-like 1Koebnerisin
02

Mechanism of action

Not applicable due to lack of known drug interactions. S100A15 acts through protein-protein interactions (with RAGE—receptor for advanced glycation end-products—and through chemotactic signaling), but there are no current drugs targeting it directly.

03

Biological functions

Regulation of keratinocyte differentiationAntimicrobial protein response (innate immunity)Inflammatory responseChemotactic factor (recruitment of immune cells)Involvement in epithelial proliferation and tumorigenesis
04

Disease associations

Inflammation (notably skin inflammation, psoriasis)Cancer (particularly epithelial cancers like breast cancer)Innate immune responseActs as a damage-associated molecular pattern (DAMP)
05

Biomarkers

Psoriatic skin (biomarker of psoriatic inflammation)Tumor progression in epithelial cancers (research context only)

Beyond the preview

Go deeper on S100 calcium binding protein A15 (S100A15).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on S100 calcium binding protein A15 (S100A15).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call